Phase 3 trials showed Vanrafia slowed the decline in kidney function for adults with the progressive autoimmune kidney ...

Lower kidney function is associated with elevated Alzheimer’s blood biomarkers, raising implications for dementia diagnosis ...

A total of 340 biopsy-confirmed IgAN patients were randomised to daily oral Vanrafia or a placebo for approximately 132 weeks.

Older adults living with heart failure with preserved ejection fraction (HFpEF) are frequently labeled as having chronic ...

It’s déjà vu all over again. Just as the kidney disease space becomes increasingly competitive, Novartis has found itself intending to turn a statistical miss into a regulatory win. | It’s déjà vu all ...

Kidney disease often creeps in silently, and many patients aren’t diagnosed until major damage is already done. New research ...

Kidney aging rarely draws attention until something goes wrong. Over time, these organs quietly lose strength, filter less efficiently, and struggle to keep the body balanced.

Aims Heart failure (HF) often coexists with chronic kidney disease (CKD), impacting prognosis. This study aims to evaluate ...

Comprehensive phosphorus management preserves residual renal function, considers dialysis modality, and minimizes intervention burden.

Many people assume that if a supplement is labelled “natural,” it must be safe. But that belief can be misleading. Several ...